A new method for oral cancer biomarkers detection with a non-invasive cyto-salivary sampling and rapid-highly sensitive ELISA immunoassay: a pilot study in humans

Abstract

IntroductionOral squamous cell carcinoma (OSCC) accounts for approximately 90% of oral malignancies and has a 5-year mortality rate close to 50%. A consistent part (70%) of all oral cancers is diagnosed at an advanced stage since available screening techniques are ineffective. Therefore, it would be urgent to improve them. The diagnostic gold standard is tissue biopsy with histological and immunohistochemical assessment. This method presents some limitations. Biopsy is invasive and the histopathological evaluation is semi-quantitative, and the absolute abundance of the target cannot be reliably determined. In addition, tissue is highly processed and may lead to loss of information of the natural state. The search for classical and new clinical biomarkers on fragments of tissue/cells collected with a cytobrush is a highly hopeful technique for early detection and diagnosis of OSCC, because of its non-invasive sampling and easy collection method.MethodsHere we analyzed cytobrush biopsies samples collected from the oral cavity of 15 patients with already diagnosed OSCC by applying an innovative high-sensitivity ELISA technique, in order to verify if this approach may provide useful information for detection, diagnosis, and prognosis of OSCC. To this end, we selected six biomarkers, already used in clinical practice for the diagnosis of OSCC (EGFR, Ki67, p53) or selected based on recent scientific and clinical data which indicate their presence or over-expression in cells undergoing transformation and their role as possible molecular targets in immunecheckpoints blockade therapies (PD-L1, HLA-E, B7-H6).ResultsThe selected tumor biomarkers were highly expressed in the tumor core, while were virtually negative in healthy tissue collected from the same patients. These differences were highly statistically significant and consistent with those obtained using the gold standard test clearly indicating that the proposed approach, i.e. analysis of biomarkers by a custom ELISA technique, is strongly reliable.DiscussionThese preliminary data suggest that this non-invasive rapid phenotyping technique could be useful as a screening tool for phenotyping oral lesions and support clinical practice by precise indications on the characteristics of the lesion, also with a view to the application of new anti-tumor treatments, such as immunotherapy, aimed at OSCC patients.

Association of podoplanin expression to histopathological grades of oral epithelial dysplasia and oral squamous cell carcinoma

“…3 Currently, histological assessment of OED in precancerous lesions is considered the gold standard for determining MTP risk. 4 However, studies indicate that there is no clear agreement on most of the clinical grading systems of OED. The accuracy of histopathological assessment of OED is largely subjective, with inter-observer and intra-observer variability.…”

Yttrium Functionalized Reduced Graphene Oxide Nanocomposite-Based Aptasensor for Ultrasensitive Detection of a Breast Cancer Biomarker

“…4,5 Overexpression of EGFR receptors and excessive levels of EGFR antigen have been associated with cancer; therefore increasing research studies have been conducted to detect EGFR in cancer patients' serum samples. 6,7 Enzymelinked immunosorbent assay, 8 PCR, 9 electron paramagnetic resonance spectrometry, 10 hydrophilic interaction liquid chromatography/mass spectrometry, 11 surface plasmon reso-nance, 12,13 and electrochemical voltammetry methods 6 are some of the analytical techniques currently used to detect EGFR. However, these techniques have limited specificity and selectivity; therefore the development of trustworthy and affordable analytical approaches for EGFR biomarker identification is of utmost importance.…”

“…Due to the associated risk and improved means of ensuring a humane healthcare system, cancer biomarker detection has recently had a noteworthy impact on cancer research. Several biomarkers, EGFR, carcinoembryonic antigen, HER-2, CA-125, CD44, etc., have been categorized as valid biomarkers associated with breast cancer. , In this context, a noteworthy biomarker over cancer tumorigenic cells is the epidermal growth factor receptor (EGFR) for which altered expression and downstream signaling cascades have been reported to be associated with the worsening of the cancerous condition. , Overexpression of EGFR receptors and excessive levels of EGFR antigen have been associated with cancer; therefore increasing research studies have been conducted to detect EGFR in cancer patients’ serum samples. , Enzyme-linked immunosorbent assay, PCR, electron paramagnetic resonance spectrometry, hydrophilic interaction liquid chromatography/mass spectrometry, surface plasmon resonance, , and electrochemical voltammetry methods are some of the analytical techniques currently used to detect EGFR. However, these techniques have limited specificity and selectivity; therefore the development of trustworthy and affordable analytical approaches for EGFR biomarker identification is of utmost importance.…”